Profund Advisors’s Sana Biotechnology SANA Stock Holding History

Profund Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$347K	Sell	99,502 -57,620	-37%	-$186K	0.01%	715
2026 Q1	$453K	Buy	157,122 +55,076	+54%	+$217K	0.02%	586
2025 Q4	$415K	Buy	102,046 +44,326	+77%	+$198K	0.01%	651
2025 Q3	$205K	Buy	+57,720	New	+$209K	0.01%	969
2025 Q2	–	Sell	-41,082	Closed	-$69K	–	1039
2025 Q1	$69K	Sell	41,082 -19,494	-32%	-$54.5K	﹤0.01%	972
2024 Q4	$98.7K	Sell	60,576 -3,575	-6%	-$10.7K	﹤0.01%	1072
2024 Q3	$267K	Buy	64,151 +1,068	+2%	+$5.61K	0.01%	868
2024 Q2	$344K	Sell	63,083 -14,119	-18%	-$113K	0.01%	642
2024 Q1	$772K	Buy	77,202 +6,499	+9%	+$48.7K	0.03%	429
2023 Q4	$288K	Buy	70,703 +15,389	+28%	+$56.7K	0.01%	798
2023 Q3	$214K	Sell	55,314 -6,163	-10%	-$33.1K	0.01%	845
2023 Q2	$366K	Sell	61,477 -14,466	-19%	-$83.4K	0.02%	617
2023 Q1	$248K	Buy	+75,943	New	+$303K	0.02%	838

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Profund Advisors's SANA Position: Q2 2026 in Review

Profund Advisors reduced its Sana Biotechnology (SANA) stake by 37% in Q2 2026, selling an estimated $186K and leaving 99,502 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #715.

Profund Advisors first reported a position in SANA in Q1 2023 and has held it in 13 quarters since. The position peaked at $772K in Q1 2024. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Profund Advisors held 99,502 shares of Sana Biotechnology worth $347K as of Q2 2026.
Profund Advisors sold 57,620 Sana Biotechnology shares in Q2 2026, an estimated $186K.
Sana Biotechnology made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #715 holding.
Profund Advisors first reported a position in Sana Biotechnology in Q1 2023 and has held it in 13 quarters since.
Profund Advisors's Sana Biotechnology position peaked at $772K in Q1 2024.
212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.